XML 28 R17.htm IDEA: XBRL DOCUMENT v3.21.2
SHARE-BASED COMPENSATION
 9 Months Ended
Sep. 26, 2021
Share-based Payment Arrangement [Abstract]  
Share-Based Compensation SHARE-BASED COMPENSATION
Stock Options

For the thirteen week periods ended September 26, 2021 and September 27, 2020, the Company recognized $0.2 million of compensation expense related to stock options. For the thirty-nine week periods ended September 26, 2021 and September 27, 2020, the Company recognized $0.5 million and $0.4 million, respectively, of compensation expense related to stock options. Unamortized share-based compensation expense as of September 26, 2021 amounted to $0.9 million which is expected to be recognized over the next 2.7 years.
 
A summary of stock option activity is presented as follows:
 Number of
Shares		Weighted Average Exercise Price Per ShareWeighted Average Remaining Contractual LifeTotal Intrinsic Value of Awards
(in thousands)
Options outstanding at December 27, 2020652,655 $17.63 7.1$665 
Granted116,374 $11.57 
Exercised(1,000)$9.72 
Forfeited / Canceled(20,150)$17.56 
Options outstanding at September 26, 2021747,879 $16.70 6.9$871 
Options exercisable at December 27, 2020416,717 $16.96 6.3$463 
Options exercisable at September 26, 2021528,315 $17.26 6.1$592 
 Number of
Shares		Weighted Average Grant Date Fair Value
Nonvested outstanding at December 27, 2020235,938 $18.83 
Nonvested outstanding at September 26, 2021219,564 $15.36 

For the thirty-nine week period ended September 26, 2021, the Company issued 213 shares of common stock upon the cashless exercise of 600 stock options.

Restricted Stock

For the thirteen week periods ended September 26, 2021 and September 27, 2020, the Company recognized $0.2 million and $0.1 million of compensation expense related to restricted stock awards. For the thirty-nine week periods ended September 26, 2021 and September 27, 2020, the Company recognized $0.4 million and $0.2 million, respectively, of compensation expense related to restricted stock awards. Unamortized share-based compensation expense as of September 26, 2021 amounted to $0.6 million which is expected to be recognized over the next 2.6 years.

A summary of restricted stock activity is presented as follows:
 Number of
Shares		Weighted Average Grant Date Fair Value
Restricted stock outstanding at December 27, 202025,218 $16.01 
Issued58,172 $11.99 
Vested(26,048)$17.51 
Restricted stock outstanding at September 26, 202157,342 $11.25 
Nonvested outstanding at December 27, 202025,218 $16.01 
Nonvested outstanding at September 26, 202157,342 $11.25 

Warrant Activity
 
For the thirteen and thirty-nine week periods ended September 26, 2021 and September 27, 2020, the Company did not recognize compensation cost related to warrants. There was no unamortized stock compensation expense to be recognized as of September 26, 2021.
 
A summary of warrant activity is presented as follows:
 Number of
Shares		Weighted Average Exercise Price Per ShareWeighted Average Remaining Contractual LifeTotal Intrinsic Value of Options
(in thousands)
Warrants outstanding at December 27, 202025,862 $16.80 0.4$— 
Forfeited(25,862)$16.80 
Warrants outstanding at September 26, 2021— $— 0.0$— 
Warrants exercisable at December 27, 202025,862 $16.80 0.4$— 
Warrants exercisable at September 26, 2021— $— 0.0$— 

There were no nonvested warrants outstanding at September 26, 2021 or December 27, 2020.

The intrinsic value in the tables above is the amount by which the market value of the underlying stock exceeded the exercise price of outstanding options or warrants, before applicable income taxes and represents the amount holders would have realized if all in-the-money options or warrants had been exercised on the last business day of the period indicated.

2020 Employee Stock Purchase Plan (“2020 ESPP”)

In November 2020, the Company's shareholders approved the 2020 ESPP. Under the 2020 ESPP, eligible team members of the Company may elect for payroll deductions to purchase shares on each purchase date during an offering period. A total of 250,000 shares of common stock of BGSF, Inc. were initially reserved for issuance pursuant to the 2020 ESPP. For the thirty-nine week period ended September 26, 2021, the Company issued 14,758 shares of common stock under the ESPP.